JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

Status unconfirmed · Not applicable

Conditions studied: Aortic Valve Stenosis, Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Ventricular Outflow Obstruction

In brief

To collect information about treatment for severe aortic stenosis (AS), which affects the aortic valve in the heart. Aortic stenosis is a narrowing of the aortic valve opening, which decreases blood flow from the heart and causes symptoms such as chest pain, fainting and shortness of breath. The preferred treatment for severe aortic stenosis is aortic valve replacement surgery.

Key facts

Study ID
NCT02732691
Run by
JenaValve Technology, Inc.
People needed
68
Starts
2016-10-21
Expected to finish
2024-04-01
Last updated by the study team
2022-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.